These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8169378)

  • 1. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity.
    Rodicio JL; Morales JM; Ruilope LM
    J Hypertens Suppl; 1993 Dec; 11(6):S21-5. PubMed ID: 8169378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological properties of lipophilic calcium antagonists.
    van Zwieten PA
    Blood Press Suppl; 1998; 2():5-9. PubMed ID: 9850436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Dec; 11(6):S3-8. PubMed ID: 8169379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation.
    Morales JM; Andres A; Rodicio JL
    Nephrol Dial Transplant; 1993; 8(9):880. PubMed ID: 8255527
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems.
    Darlametsos IE; Papanikolaou EN; Varonos DD
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):263-9. PubMed ID: 11090252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
    Rodicio JL
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S7-11. PubMed ID: 11347860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
    Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
    Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis.
    Raman GV; Campbell SK; Farrer A; Albano JD; Cook J
    J Hypertens Suppl; 1998 Sep; 16(4):S39-41. PubMed ID: 9817191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
    Segura J; García-Donaire JA; Ruilope LM
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):422-6. PubMed ID: 17693756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and renal protection.
    Rodicio JL; Morales JM; Alcázar JM; Ruilope LM
    J Hypertens Suppl; 1993 Mar; 11(1):S49-53. PubMed ID: 8483023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.